Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Clinical risk

Low Minor surgery, age less than 40 years, and no clinical risk factors 2 0.2 0.002 Ambulation... [Pg.140]

Moderate Major or minor surgery, age 40-60 years, and no clinical risk factors Major surgery, age less than 40 years, and no clinical risk factors Minor surgery, with clinical risk factor(s) Acutely ill (e.g., myocardial infarction, ischemic stroke, heart failure exacerbation), and no clinical risk factors 10-20 1-2 I o UFH 5000 units SC every 12 hours Dalteparin 2500 units SC every 24 hours Enoxaparin 40 mg SC every 24 hours Tinzaparin 3500 units SC every 24 hours IPC Graduated compression stockings... [Pg.140]

Review the patient s medical and social history. Was the patient exposed to clinical risk factors for lung cancer ... [Pg.1338]

In summary, the true association between most dietary factors and the risk of colon cancer is unclear. The protective effects of fiber, calcium, and a diet low in fat are not completely known. Lifestyle factors such as NSAID use and hormone use appear to decrease the risk of colorectal cancer, whereas physical inactivity, alcohol use, and smoking appear to increase the risk of colon cancer. Clinical risk factors and genetic mutations are well-known risks for colon cancer. [Pg.1344]

R. H. Lavey, and J. K. Penny (eds.), Idiosyncratic Reactions to Valproate Clinical Risk Patterns and Mechanism of Toxicity, Raven Press, New York, 1991, pp. 19-24. [Pg.240]

Major surgery, age <40 years and no clinical risk factors Minor surgery, with clinical risk factor(s)... [Pg.189]

Acutely ill (e.g., Ml, ischemic stroke, CHF exacerbation), and no clinical risk factors High... [Pg.189]

Major surgery, age >60 years, and no clinical risk factors Major surgery, age 40-60 years, with clinical risk factor(s) Acutely ill (e.g., Ml, ischemic stroke, CHF exacerbation), with risk factor(s)... [Pg.189]

Prognosis depends on histologic subtype and clinical risk factors (e.g., age more than 60 years, performance status of 2 or more, elevated lactic dehydrogenase, extranodal involvement, and stage III or IV disease). These risk factors are used to calculate the International Prognostic Index. [Pg.721]

Boreham N.C., Shea C.E., Mackway-Jones K., 2000. Clinical risk and collective competence in the hospital emergency department in the UK, Social Science Medicine 51, pp. 83-91. [Pg.147]

O Brien B. What are My Chances Doctor A Review of Clinical Risks. London Office of Health Economics, 1986. [Pg.447]

Consumption of soy foods (providing 60mg/day isoflavones) for 12 weeks by postmenopausal women has been found to significantly decrease clinical risk factors for osteoporosis (short-term markers of bone turnover) including decreased urinary M-telopeptide excretion (bone resorption marker) and increased serum osteocalcin (bone formation marker). Furthermore, consumption of a soy isoflavone supplement containing 61.8 mg of isoflavones for 4 weeks by postmenopausal Japanese women significantly decreased excretion of bone resorption markers. ... [Pg.386]

Scheiber MD, Liu, JH, Subbiah, MTR, Rebar RW, Setchell KDR. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8, 384-392, 2001. [Pg.394]

Ma DQ, Jones G. Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 2002 38(5) 497-500. [Pg.91]

Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. 2000. Vascular superoxide production by NAD(P)H oxidase Association with endothelial dysfunction and clinical risk factors. Circ Res 86 E85-90. [Pg.210]

Nawaz S, Cleveland X Gaines PA, Chan R Clinical risk associated with contrast angiography in metformin treated patients a clinical review. Clin Radiol 1998 53 342-344. [Pg.464]

Zabalgoitia M, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 1998 3 I (7) 1622-1626. [Pg.490]

Porubek DJ, Grillo MP, Olsen RK, et al. Toxic metabolites of valproic acid inhibition of rat liver acetoacetyl-CoA thiolase by 2-n-propyl-4-pentenoic acid (A4-VP A) and related branched chain carboxylic acids. In Levy RH, Penry JK, eds. Idiosyncratic Reactions to Valproate Clinical Risk Patterns and Mechanisms of Toxicity. New York Raven Press, 1991 53-58. [Pg.703]

These methods can be adopted to define dose relationships - as was the intent of the open epicutaneous test (OET). The availability of the threshold for induction (TIC) and elicitation (TEC) provides a valuable tool in clinical risk assessment. [Pg.370]

Echocardiogram is not needed for routine assessment, but refines clinical risk stratification in the case of moderate or severe left ventricular dysfunction and... [Pg.437]

Lucas GM, Chaisson RE, Moore RD (1999) Highly acdve andretroviral therapy in a large urban clinic Risk factors for virologic failure and adverse drug reacdons. Arm hr tern Med 131 81-87. [Pg.618]


See other pages where Clinical risk is mentioned: [Pg.845]    [Pg.1324]    [Pg.253]    [Pg.491]    [Pg.65]    [Pg.69]    [Pg.69]    [Pg.75]    [Pg.410]    [Pg.138]    [Pg.175]    [Pg.81]    [Pg.120]    [Pg.268]    [Pg.319]    [Pg.328]    [Pg.404]    [Pg.64]    [Pg.221]    [Pg.69]   


SEARCH



© 2024 chempedia.info